A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pirbuterol
Terlipressin
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Terlipressin.
Pirbuterol
Aceprometazine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Aceprometazine.
Pirbuterol
Probucol
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Probucol.
Pirbuterol
Dimetacrine
The risk or severity of hypertension can be increased when Mirabegron is combined with Dimetacrine.
Pirbuterol
Tianeptine
The risk or severity of hypertension can be increased when Mirabegron is combined with Tianeptine.
Pirbuterol
Imipramine oxide
The risk or severity of hypertension can be increased when Imipramine oxide is combined with Mirabegron.
Pirbuterol
Iprindole
The risk or severity of hypertension can be increased when Iprindole is combined with Mirabegron.
Pirbuterol
Lofepramine
The risk or severity of hypertension can be increased when Lofepramine is combined with Mirabegron.
Pirbuterol
Melitracen
The risk or severity of hypertension can be increased when Melitracen is combined with Mirabegron.
Pirbuterol
Quinupramine
The risk or severity of hypertension can be increased when Quinupramine is combined with Mirabegron.
Pirbuterol
Dibenzepin
The risk or severity of hypertension can be increased when Dibenzepin is combined with Mirabegron.
Pirbuterol
Amitriptylinoxide
The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Mirabegron.
Pirbuterol
Oxaprotiline
The risk or severity of hypertension can be increased when Oxaprotiline is combined with Mirabegron.
Pirbuterol
Amineptine
The risk or severity of hypertension can be increased when Amineptine is combined with Mirabegron.
Pirbuterol
Urapidil
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Urapidil.
Pirbuterol
Bunazosin
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bunazosin.
Pirbuterol
Trimazosin
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Trimazosin.
Pirbuterol
Indoramin
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Indoramin.
Pirbuterol
Thioproperazine
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Thioproperazine.
Pirbuterol
Acepromazine
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Acepromazine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3